Skip to textbook content
Doctor’s PassportTextbook
TopicsAll topics

Loading topic navigation…

Textbook navigation
TopicsAll topics

Loading topic navigation…

Educational draft · awaiting clinical reviewUse Rapid for revision, not patient-care decisions. Check current national and local guidance and the BNF or BNFC before acting.

Major haemorrhage planning

Palliative and end-of-life care · UK scope · Sources checked 27 Aug 2026 · Clinical review pending

RapidFull
!
Active catastrophic haemorrhage

A large bleed can cause airway obstruction, shock, panic and death within minutes. The first response must follow the previously agreed goal while ensuring no conscious patient is left alone.

Action: Call for help, stay with the person, use a calm voice, safe positioning and direct pressure when possible and cover visible blood with dark towels. Activate emergency major-haemorrhage care if rescue is intended; for a terminal comfort plan, give prescribed rapid midazolam by the authorised feasible route if distress persists and avoid separating reassurance from medicine delivery.

Synopsis

Identify people at credible risk of catastrophic bleeding, reduce preventable causes, agree resuscitative or comfort priorities, prepare teams and carers without causing avoidable alarm and respond with presence, haemostasis and rapid anxiolysis.

  • Catastrophic haemorrhage is rapid, life-threatening bleeding from tumour erosion, vessel fistula, ulceration, thrombocytopenia, coagulopathy or anticoagulant effect; risk must be individualised rather than assumed from diagnosis alone.
  • Sentinel bleeds, pulsatile tumour, threatened carotid or major vessel on imaging, recurrent haemoptysis or haematemesis and worsening thrombocytopenia demand urgent specialist review.
  • First-line prevention treats an achievable source: local pressure or dressing, radiotherapy, endoscopy, embolisation, surgery, antifibrinolytic or correction of anticoagulant and haematological factors as appropriate.
  • Ask how much the patient and family want to know, explain uncertainty and distinguish a preparedness plan from a prediction that bleeding will occur.
  • Record whether an actual event should trigger full resuscitation and major-haemorrhage protocol, limited hospital treatment or comfort-only care; DNACPR alone does not answer this.
  • At a terminal catastrophic bleed, stay with the person, call for help, use calm voice and touch, position safely, apply pressure when feasible and use dark towels to reduce visual distress.
  • Do not leave a conscious frightened patient to search for medicine. Human presence and reassurance are the immediate treatment, because death may occur before a sedative can act.
  • When distress persists long enough, give the locally authorised rapid midazolam rescue by the fastest feasible route; route, dose and access must be prescribed and prepared in advance.
  • Protect carers and staff with gloves and a post-event debrief, practical cleaning support and bereavement follow-up; witnessing a bleed can be traumatic.
  • The gold-standard plan is short, visible and operational: who to call, what to do, where equipment and medicine are, what not to attempt and how the team supports survivors.

Key red flags

Any sentinel bleed from a tumour close to a major vessel warrants urgent review even if observations recover.

Pulsatile bleeding or a new bruit in an ulcerated neck or groin tumour suggests arterial involvement.

Haemoptysis with airway compromise, falling oxygenation or inability to clear blood requires immediate airway and respiratory support.

Haematemesis, melaena, abdominal pain or collapse may indicate arterial gastrointestinal bleeding or aorto-enteric fistula.

Tachycardia, hypotension, mottling, confusion or syncope indicates clinically important loss despite uncertain measured volume.

A rapidly falling platelet count, fibrinogen or haemoglobin can precede overt bleeding in marrow failure or disseminated coagulation.

A DNACPR form does not establish whether transfusion, embolisation, endoscopy or emergency transfer is wanted.

Catastrophic terminal event

Uncontrollable high-volume bleeding with rapid loss of consciousness may leave only minutes for presence, pressure and preplanned comfort treatment.

Investigation priorities

01
First-line bleeding history and source examinationFirst stepFirst line

Define site, volume, tempo, sentinel episodes, triggers, accessible pressure points, tumour anatomy and current antithrombotic treatment.

Management branches

Risk reductionTreat the source before catastrophe

Sentinel bleeding or anatomy indicates a credible major-haemorrhage risk and intervention may provide worthwhile benefit.

  1. Escalate to the relevant oncology, surgery, endoscopy or interventional team and define source, vessel involvement, haemostatic defects and current antithrombotics.
  2. Choose local care, radiotherapy, embolisation, covered stent, endoscopic therapy, surgery, reversal or component support according to mechanism and goal.
  3. Document treatment response and residual risk, then build a crisis plan even when preventive treatment appears successful.

Key medicines

Pre-authorised midazolam for terminal bleeding panicA common specialist crisis prescription is midazolam 10 mg by intravenous, intramuscular or buccal route according to existing access and local palliative protocol, repeated only under the documented response plan.The event may be faster than drug effect, so never delay presence; route and administrator must be lawful and feasible and frailty, prior benzodiazepine exposure and respiratory state require the prewritten plan.
Tranexamic acid for selected non-terminal bleedingUse a site-specific oral, topical or intravenous regimen only after thrombosis, renal function, haematuria and the intended haemostatic procedure have been reviewed under the local bleeding pathway.It is not universal treatment for every tumour bleed; adjust in renal impairment and avoid uncritical use with upper urinary-tract bleeding or major thrombotic risk.
Open full textbook →Answer 2 questions
Sources and review status4 sources · checked 27 Aug 2026 · clinical review pending+
Sources

Sources and review status

National guidance is shown before implementation-dependent detail. Typical adult dose examples remain subject to patient factors, contraindications and the live BNF or specialist protocol. Source check completed 27 Aug 2026; clinical approval remains outstanding.

  • Scottish Palliative Care Guidelines bleedingBleeding prevention, catastrophic haemorrhage preparation and crisis medicines.
  • NICE NG24 blood transfusionBlood components, patient identification, monitoring and major haemorrhage principles.
  • BNF midazolam monographRoutes, respiratory effects, interactions and benzodiazepine safety.
  • GMC end-of-life treatment guidanceShared decisions, emergency planning, capacity and continuity near death.

Editorial contact: Doctor’s Passport editorial team. Source-check date is separate from clinical approval. Report a content problem · Content changes

Authoring stateRapid draftClinical stateAwaiting reviewJurisdictionUnited Kingdom